195 related articles for article (PubMed ID: 12126571)
1. [Experimental study on adenovirus-mediated transfer of p53 or adenovirus- mediated transfer of p53 combined with radiotherapy for human cervical cancer cell line HeLa cells].
Kong W; Sun J; Lin C; Zha Y; Lu G; Fu M; Zhang X
Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):352-5. PubMed ID: 12126571
[TBL] [Abstract][Full Text] [Related]
2. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin].
Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
[TBL] [Abstract][Full Text] [Related]
4. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
Qi X; Chang Z; Song J; Gao G; Shen Z
Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
[TBL] [Abstract][Full Text] [Related]
6. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus carrying TIMP-3: a potential tool for cervical cancer treatment.
Zhang Y; Qian H; Lin C; Lang J; Xiang Y; Fu M; Zhang X; Liang X
Gynecol Oncol; 2008 Jan; 108(1):234-40. PubMed ID: 17976707
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer.
Modesitt SC; Ramirez P; Zu Z; Bodurka-Bevers D; Gershenson D; Wolf JK
Clin Cancer Res; 2001 Jun; 7(6):1765-72. PubMed ID: 11410518
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ
Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
Zuo ZH; Zhao M; Liu J; Wei Y; Wu XX
Ai Zheng; 2006 Jul; 25(7):811-7. PubMed ID: 16831269
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of tongue cancer development in nude mice transfected with adenovirus carrying human endostatin gene].
Ding XQ; Chen Y; Li L; Liu RY; Huang JL; Lai K; Wu XJ; Ke ML; Huang WL
Ai Zheng; 2003 Nov; 22(11):1152-7. PubMed ID: 14613642
[TBL] [Abstract][Full Text] [Related]
12. Bladder cancer therapy using combined proliferating cell nuclear antigen antisense oligonucleotides and recombinant adenovirus p53.
Zhu Z; Xing S; Lin C; Zhang X; Fu M; Liang X; Zeng F; Lu G; Wu M
Chin Med J (Engl); 2003 Dec; 116(12):1860-3. PubMed ID: 14687474
[TBL] [Abstract][Full Text] [Related]
13. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
Oakley R; Phillips E; Hooper R; Wilson D; Partridge M
Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic effects of hTR-siRNA adenovirus on human cervical cancer xenografts in nude mice].
Li WY; Li MY; Xiao LY; Zhang CL; Liu YR; Li XY; Zhang SY; Li Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):711-4, 731. PubMed ID: 19024296
[TBL] [Abstract][Full Text] [Related]
15. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
[TBL] [Abstract][Full Text] [Related]
16. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ
Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938
[TBL] [Abstract][Full Text] [Related]
17. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
Dong YB; Yang HL; McMasters KM
Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic potential of recombinant adenovirus expressing p53 in hepatocellular carcinoma cell lines].
Guo Y; Zeng Y; Wang K; Zhu X; Luo H; Zheng M; Li M; Chen J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():43-5. PubMed ID: 11509137
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
Hamada K; Alemany R; Zhang WW; Hittelman WN; Lotan R; Roth JA; Mitchell MF
Cancer Res; 1996 Jul; 56(13):3047-54. PubMed ID: 8674061
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo.
Ghaneh P; Greenhalf W; Humphreys M; Wilson D; Zumstein L; Lemoine NR; Neoptolemos JP
Gene Ther; 2001 Feb; 8(3):199-208. PubMed ID: 11313791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]